所有图片(1)
About This Item
线性分子式:
K3Fe(CN)6
CAS号:
分子量:
329.24
EC號碼:
MDL號碼:
分類程式碼代碼:
12171602
PubChem物質ID:
NACRES:
NA.25
推荐产品
等級
reagent grade
產品線
BioUltra
化驗
≥99.0% (RT)
形狀
crystals
雜質
insoluble matter, passes filter test
pH值
6-9 (25 °C, 1 M in H2O)
溶解度
H2O: 1 M at 20 °C, clear, very strong brownish-yellow
負離子痕跡
chloride (Cl-): ≤50 mg/kg
hexacyanoferrate(II) ([Fe(CN)6]4-): ≤200 mg/kg
sulfate (SO42-): ≤50 mg/kg
正離子痕跡
As: ≤0.1 mg/kg
Ca: ≤5 mg/kg
Cd: ≤5 mg/kg
Co: ≤50 mg/kg
Cr: ≤50 mg/kg
Cu: ≤10 mg/kg
Mg: ≤5 mg/kg
Mn: ≤5 mg/kg
Na: ≤200 mg/kg
Ni: ≤10 mg/kg
Pb: ≤20 mg/kg
Sr: ≤5 mg/kg
Zn: ≤5 mg/kg
吸收
no transmittance (UV) in H2O at 1 M
SMILES 字串
[K+].[K+].[K+].N#C[Fe-3](C#N)(C#N)(C#N)(C#N)C#N
InChI
1S/6CN.Fe.3K/c6*1-2;;;;/q;;;;;;-3;3*+1
InChI 密鑰
MIMJFNVDBPUTPB-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
相关类别
應用
在流动注射化学发光和激光诱导荧光等检测系统中，六氰合铁酸钾 (Ⅲ)（红普鲁士酸）可作为电子受体。
其他說明
电子受体，用于涉及电子传递的系统，例如 NADH-细胞色素 b 5 还原酶 ；复合物 I 的含量测定
訊號詞
Warning
危險聲明
危險分類
Aquatic Chronic 2 - Eye Irrit. 2
安全危害
儲存類別代碼
13 - Non Combustible Solids
水污染物質分類（WGK）
WGK 2
閃點（°F）
Not applicable
閃點（°C）
Not applicable
個人防護裝備
Eyeshields, Gloves
其他客户在看
Incorporation of microsomal electron-transfer components into liposomes: considerations for diffusion-limited reactions.
P Strittmatter et al.
Methods in enzymology, 52, 206-211 (1978-01-01)
Detergent-solubilized NADH-cytochrome b5 reductase.
K Mihara et al.
Methods in enzymology, 52, 102-108 (1978-01-01)
Preparation and properties of NADH: ubiquinone oxidoreductase (complexI), EC 1.6.5.3.
Y Hatefi
Methods in enzymology, 53, 11-14 (1978-01-01)
Soichiro Ijiri et al.
Journal of chromatography. A, 1217(18), 3161-3166 (2010-03-23)
Rhodamine 110 (Rho110) has been used in the highly sensitive analysis of monosaccharides, as it reacts with the reducing carbonyl group of the saccharides. The monosaccharide derivatives were investigated by capillary electrophoresis with laser-induced fluorescence detection. The derivatization was performed
Hideo Takakusa et al.
Drug metabolism and disposition: the biological fate of chemicals, 39(6), 1022-1030 (2011-03-03)
Lapatinib, an oral breast cancer drug, has recently been reported to be a mechanism-based inactivator of cytochrome P450 (P450) 3A4 and also an idiosyncratic hepatotoxicant. It was suggested that formation of a reactive quinoneimine metabolite was involved in mechanism-based inactivation
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门